Fig. 2From: Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma modelsTreatment of established B16F10 and LLC tumours with purified Reovirus administered IT. a Survival and (c) tumour volume of B16F10 tumours in C57Bl/6j mice (n = 5) following treatment with Reovirus in an escalating dose regimen. b Survival and (d) tumour volume of LLC tumours following the same regimen in C57Bl/6j mice (n = 5)Back to article page